Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Patents|January 10, 2022
Selective TYK2 inhibitors as potential therapeutic agents: a patent review (2019-2021)Felix Gonzalez Lopez de Turiso, Kevin Guckian
Molecular and Cellular Neurosciences|July 12, 2011
Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivoYinghui Hu, Xinhua Lee, Benxiu Ji, et al.
Chembiochem : a European Journal of Chemical Biology|April 22, 2021
Chemoproteomic Profiling of Covalent XPO1 Inhibitors to Assess Target Engagement and SelectivityJeffrey G Martin, Jennifer A Ward, Felix Feyertag, et al.
Structure (London, England : 1993)|May 9, 2008
Structure of a NEMO/IKK-associating domain reveals architecture of the interaction siteMia Rushe, Laura Silvian, Sarah Bixler, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
ILC2s navigate tissue redistribution during infection using stage-specific S1P receptorsTakamasa Ito, Yoshihiro Ishida, Yingyu Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2009
Pyrazolone based TGFbetaR1 kinase inhibitorsKevin Guckian, Mary Beth Carter, Edward Yin-Shiang Lin, et al.
Nucleic Acids Research|April 26, 2023
Controlled sulfur-based engineering confers mouldability to phosphorothioate antisense oligonucleotidesVito Genna, Javier Iglesias-Fernández, Laura Reyes-Fraile, et al.
Science Immunology|March 13, 2026
Inflammatory ILC2s migrate to distal tissues during infection using stage-specific S1P receptorsTakamasa Ito, Christine F Wu, Yingyu Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2023
Development of a PET Tracer for OGA with Improved Kinetics in the Living BrainBrendon E Cook, Sangram Nag, Ryosuke Arakawa, et al.
Pageof 1